Variant report
Variant | nsv974447 |
---|---|
Chromosome Location | chr14:22260663-22267332 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:66)
- CpG islands (count:61)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:22265369-22265419 | NB4 | blood: | n/a |
2 | chr14:22265369-22265419 | ECC-1 | luminal epithelium: | n/a |
3 | chr14:22265369-22265419 | GM06990 | blood: | n/a |
4 | chr14:22265369-22265419 | HNPCEpiC | eye: | n/a |
5 | chr14:22265369-22265419 | BJ | skin: | n/a |
6 | chr14:22265369-22265419 | K562 | blood: | n/a |
7 | chr14:22265369-22265419 | NT2-D1 | testis: | n/a |
8 | chr14:22265369-22265419 | T-47D | breast: | n/a |
9 | chr14:22265369-22265419 | HEK293 | kidney: | embryo |
10 | chr14:22265369-22265419 | IMR90 | lung: | fetal |
11 | chr14:22265369-22265419 | H1-hESC | embryonic stem cell: | embryo |
12 | chr14:22265369-22265419 | HAEpiC | amniotic membrane: | n/a |
13 | chr14:22265369-22265419 | HCM | heart: | n/a |
14 | chr14:22265369-22265419 | HCF | heart: | n/a |
15 | chr14:22265369-22265419 | HRPEpiC | eye: | n/a |
16 | chr14:22265369-22265419 | Hepatocyte | liver: | n/a |
17 | chr14:22265369-22265419 | Hela-S3 | cervix: | n/a |
18 | chr14:22265369-22265419 | NHDF-neo | bronchial: | n/a |
19 | chr14:22265369-22265419 | SK-N-MC | brain: | n/a |
20 | chr14:22265369-22265419 | U87 | brain: | n/a |
21 | chr14:22265369-22265419 | LNCaP | prostate: | n/a |
22 | chr14:22265369-22265419 | ovcar-3 | ovarian: | n/a |
23 | chr14:22265369-22265419 | GM12878 | blood: | n/a |
24 | chr14:22265369-22265419 | ProgFib | skin: | n/a |
25 | chr14:22265369-22265419 | PANC-1 | pancreas: | n/a |
26 | chr14:22265369-22265419 | BE2_C | brain: | n/a |
27 | chr14:22265369-22265419 | HEEpiC | esophagus: | n/a |
28 | chr14:22265369-22265419 | Jurkat | blood: | n/a |
29 | chr14:22265369-22265419 | GM12891 | blood: | n/a |
30 | chr14:22265369-22265419 | CMK | blood: | n/a |
31 | chr14:22265369-22265419 | SAEC | small airway: | n/a |
32 | chr14:22265369-22265419 | Caco-2 | colon: | n/a |
33 | chr14:22265369-22265419 | HL-60 | blood: | n/a |
34 | chr14:22265369-22265419 | NH-A | brain: | n/a |
35 | chr14:22265369-22265419 | AoSMC | blood vessel: | n/a |
36 | chr14:22265369-22265419 | A549 | lung: | n/a |
37 | chr14:22265369-22265419 | PrEC | prostate: | n/a |
38 | chr14:22265369-22265419 | MCF-7 | breast: | n/a |
39 | chr14:22265369-22265419 | AG09319 | gingival: | n/a |
40 | chr14:22265369-22265419 | MCF10A-Er-Src | breast: | n/a |
41 | chr14:22265369-22265419 | HIPEpiC | eye: | n/a |
42 | chr14:22265369-22265419 | SK-N-SH | brain: | n/a |
43 | chr14:22265369-22265419 | PFSK-1 | brain: | n/a |
44 | chr14:22265369-22265419 | AG09309 | skin: | n/a |
45 | chr14:22265369-22265419 | HPAEpiC | pulmonary alveolar: | n/a |
46 | chr14:22265369-22265419 | SK-N-SH_RA | brain: | n/a |
47 | chr14:22265369-22265419 | AG10803 | skin: | n/a |
48 | chr14:22265369-22265419 | AG04449 | skin: | fetal |
49 | chr14:22265369-22265419 | RPTEC | kidney: | n/a |
50 | chr14:22265369-22265419 | HepG2 | liver: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
TRAV8-1 | TF binding region |
TRAV8-1 | CpG island |
ENSG00000211784 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545010100 | chr14:22261618-22261619 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564756025 | chr14:22261632-22261633 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530818497 | chr14:22261673-22261674 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs80216932 | chr14:22261693-22261694 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs144163720 | chr14:22261695-22261696 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs8005936 | chr14:22261724-22261725 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs182636496 | chr14:22261726-22261727 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs2874143 | chr14:22261739-22261740 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs569210408 | chr14:22261754-22261755 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs556789502 | chr14:22261758-22261759 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs186659223 | chr14:22261785-22261786 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs538786786 | chr14:22261809-22261810 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs578093419 | chr14:22261826-22261827 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs545584001 | chr14:22261849-22261850 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs558898523 | chr14:22261853-22261854 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371494756 | chr14:22261857-22261858 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375854841 | chr14:22261863-22261864 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569199305 | chr14:22261916-22261917 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529607712 | chr14:22261973-22261974 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550965284 | chr14:22261991-22261992 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548158621 | chr14:22263200-22263201 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76857743 | chr14:22263317-22263318 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs74895313 | chr14:22263328-22263329 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs187888635 | chr14:22263355-22263356 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs146216865 | chr14:22263427-22263428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs33989906 | chr14:22263465-22263466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs397774431 | chr14:22263471-22263472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs193065108 | chr14:22263487-22263488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7155064 | chr14:22263534-22263535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574936331 | chr14:22263658-22263659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185355120 | chr14:22263700-22263701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558592203 | chr14:22263739-22263740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575226068 | chr14:22263749-22263750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78721424 | chr14:22263758-22263759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554593722 | chr14:22263796-22263797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538551024 | chr14:22263798-22263799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12434548 | chr14:22263821-22263822 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs144948044 | chr14:22263827-22263828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560199900 | chr14:22263844-22263845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189810139 | chr14:22263860-22263861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs138869293 | chr14:22263866-22263867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12897844 | chr14:22263930-22263931 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs538201112 | chr14:22263935-22263936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562732964 | chr14:22263957-22263958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531678436 | chr14:22263978-22263979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs149387340 | chr14:22263979-22263980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs116960842 | chr14:22263982-22263983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561743440 | chr14:22264046-22264047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557604501 | chr14:22264145-22264146 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs34888533 | chr14:22264160-22264161 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cone-rod dystrophy | 18421352 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Alzheimer''s disease | 21482944 | CNVD |
Mental retardation | 19951919 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 16773561 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17440070 | CNVD |
Breast cancer | 16272173 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
severe speech impairment | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:22261600-22262000 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
2 | chr14:22263200-22263400 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
3 | chr14:22263400-22265200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr14:22265000-22265400 | Active TSS | Thymus | Thymus |
5 | chr14:22265200-22265600 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
6 | chr14:22265400-22265800 | Enhancers | Brain Anterior Caudate | brain |
7 | chr14:22265400-22265800 | Flanking Active TSS | Thymus | Thymus |
8 | chr14:22265400-22266000 | Active TSS | Primary T cells fromperipheralblood | blood |
9 | chr14:22265400-22266000 | Enhancers | Fetal Thymus | thymus |
10 | chr14:22265600-22266000 | Active TSS | Primary T regulatory cells fromperipheralblood | blood |
11 | chr14:22265800-22267600 | Active TSS | Thymus | Thymus |